ACC.24 Congress Coverage: KARDIA-2 trial Daily cardiology
-
- Medisin
ACC.24: Zilebesiran as Add-on Therapy in Patients with Hypertension Not Adequately Controlled by a Standard of Care
ACC.24: Zilebesiran as Add-on Therapy in Patients with Hypertension Not Adequately Controlled by a Standard of Care
9 min